Cell-based bioassay and potency development and operation require the correct partner because they are among the trickiest techniques needed in the drug development process. In vitro bioassays are essential for determining potency but they can also evaluate biological activity between the mAb, its target, and Fc effector activities in a way that is truly physiologically relevant.
• Assays for antibody-dependent cell-mediated cytotoxicity
• Assays for antibody-dependent cellular phagocytosis
• CDC Assays for Complement-Dependent Cytotoxicity
We offer a detection solution through the Mechanism of Action (MOA), from early candidate selection and product characterization to production. Flexible endpoints are possible with our testing methodology, enabling a more thorough evaluation of MOA.
